Back

The incidence and clinical significance of de novo depression after shock delivery in cardiac resynchronization therapy recipients.

27 August 2016 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 7 - Optimising results of cardiac resynchronisation therapy and clinical results and left ventricular lead placement Resynchronisation therapy ESC Premium Access ESC Congress 2016

About the speaker

Photo
Assistant Professor Tomasz Podolecki

Silesian Center for Heart Diseases (SCHD), Zabrze (Poland)

24 More presentations in this session

Presentation thumbnail
Prognostic predictors of cardiac resynchronization therapy in patients with renal dysfunction
Doctor R. Ilhao Moreira (Lisbon, PT)
Abstract
Presentation thumbnail
Effect of cardiac resynchronizing therapy on prevention and development of ventricular tachycardia episodes in patients with non-ischemic cardiomyopathy
Doctor D. Lebedev (Kemerovo, RU)
Presentation thumbnail
Improving biventricular pacing percentage through clinic level remote monitoring data
Mrs A. Patel (Apex, US)
Abstract Slides
Presentation thumbnail
Usefulness of cardiac resynchronization therapy in patients aged over 75 years as compared with medical therapy
Doctor M. Cortes Garcia (Madrid, ES)
Abstract Slides
Presentation thumbnail
Impact of QRS complex duration versus morphology on left ventricular reverse remodelling after cardiac resynchronisation therapy
Doctor P. Van Der Bijl (Cape Town, ZA)
Abstract Slides

Access the full session

Session thumbnail
Poster session 7 - Optimising results of cardiac resynchronisation therapy and clinical results and left ventricular lead placement

The Event

Event poster

ESC Congress 2016

27 August - 31 August 2016

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources